These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7349614)

  • 1. [Clinical value of the determination of anti-arrhythmia drugs in the plasma].
    Ferrari M; Malini PL; Padrini R; Costa FV; Gobbato S; Ambrosioni E
    Boll Soc Ital Cardiol; 1980; Suppl():91-100. PubMed ID: 7349614
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibilities of clinical pharmacology in the evaluation of anti-arrhythmia and anti-angina drugs].
    Mazur NA; Metelitsa VI
    Farmakol Toksikol; 1982; 45(3):59-63. PubMed ID: 7095129
    [No Abstract]   [Full Text] [Related]  

  • 3. [Active metabolites of anti-arrhythmia drugs].
    Matusewicz W
    Postepy Hig Med Dosw; 1985; 39(2):133-49. PubMed ID: 3900963
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relation between pharmacodynamics and the pharmacokinetics of anti-arrhythmia agents].
    Gneushev ET; Starodubtsev AK; Kurapov AP; Kukes VG; Zisel'man SB
    Farmakol Toksikol; 1982; 45(3):107-10. PubMed ID: 7095120
    [No Abstract]   [Full Text] [Related]  

  • 5. New concepts for antiarrhythmic drugs in the 1980's.
    Harrison DC; Irwin WG
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():73-7. PubMed ID: 6803704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of plasma concentrations of anti-arrhythmia agents].
    Flouvat B
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():47-55. PubMed ID: 6803701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy control in cardiology: serum level monitoring].
    Ochs HR
    Z Kardiol; 1984 Oct; 73(10):605-12. PubMed ID: 6516513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-arrhythmic activity of quaternary derivatives of trimecaine in experimental ventricular arrhythmias].
    Gendenshteĭn EI; Tsybusov AP; Zhukauskaĭte LN; Stankevichius AP
    Biull Eksp Biol Med; 1982 Nov; 94(11):55-7. PubMed ID: 7150740
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacology of old and new antiarrhythmic drugs.
    Nattel S; Zipes DP
    Cardiovasc Clin; 1980; 11(1):221-48. PubMed ID: 7002302
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemical structure, conformation and activity of drugs].
    Hanc O
    Cesk Farm; 1973 Feb; 22(1):44-8. PubMed ID: 4691549
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of pharmacokinetic studies in the clinical phase of experimentation with anti-arrhythmia agents].
    Jaillon P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():57-64. PubMed ID: 6803702
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical application of pharmacokinetics for antiarrhythmic drugs.
    Harrison DC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():65-72. PubMed ID: 6803703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and pharmacology of antiarrhythmic drugs.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am Heart J; 2000 Jul; 140(1):12-20. PubMed ID: 10874257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basic problems of antiarrhythmic treatment (author's transl)].
    Follath F
    Schweiz Rundsch Med Prax; 1981 Sep; 70(37):1583-8. PubMed ID: 7053142
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methods for evaluating anti-arrhythmia drugs in man].
    Lekieffre J; Libersa C; Caron J; Kacet S; Marchand X
    Rev Prat; 1986 Nov; 36(53):3115-8, 3121-9. PubMed ID: 3809930
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current clinical interest in monitoring digoxinemia].
    Salerno L; Di Fede G; Pepe S; Iacò V
    Clin Ter; 1995 Dec; 146(12):775-9. PubMed ID: 8681497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between anti-arrhythmia effect and pharmacological data of Brufacaine in parenteral and oral administration in man].
    Burhorn D; Siegers CP; Diederich KW
    Verh Dtsch Ges Inn Med; 1975; 81():187-90. PubMed ID: 1229491
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiarrhythmic effect related to the plasma concentration of pentisomide in vivo and the antiarrhythmic-concentration relationship in vitro.
    Hachisu M; Chen H; Soneda T; Fujishima K; Ishizuka T; Konno F
    Drugs Exp Clin Res; 1995; 21(4):145-51. PubMed ID: 8529527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac arrhythmias (III). The classification of anti-arrhythmia drugs in the 90s: a focus for the cardiologist].
    Tamargo J; Valenzuela C; Delpón E
    Rev Esp Cardiol; 1993 Mar; 46(3):183-94. PubMed ID: 8387683
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma CPU-86017 concentrations regarding suppression of ouabain-induced cardiac arrhythmias and decrease of heart rate in guinea pigs.
    Khan HH; Dai DZ; Xiao DW; Lin S; Wang ZZ; Lou S; Qing Q
    Acta Pharmacol Sin; 2000 Nov; 21(11):1039-42. PubMed ID: 11501061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.